F von Weizsacker
Overview
Explore the profile of F von Weizsacker including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
53
Citations
408
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
von Weizsacker F, Maio G
Dtsch Med Wochenschr
. 2010 Apr;
135(16):819-21.
PMID: 20391316
The current DRG system has not only changed the economic structure of clinical medicine but also has profound effects on its original mission. In the present paper we discuss the...
2.
Klingmuller U, Bauer A, Bohl S, Nickel P, Breitkopf K, Dooley S, et al.
Syst Biol (Stevenage)
. 2006 Dec;
153(6):433-47.
PMID: 17186705
Complex cellular networks regulate regeneration, detoxification and differentiation of hepatocytes. By combining experimental data with mathematical modelling, systems biology holds great promises to elucidate the key regulatory mechanisms involved and...
3.
von Weizsacker F
Praxis (Bern 1994)
. 2005 May;
94(16):649-52.
PMID: 15900829
As a leading cause of liver cirrhosis and hepatocellular carcinoma, chronic hepatitis B poses a major health care problem. Currently approved therapeutic options include interferon-alpha, pegylated interferon-alpha, lamivudine and adefovir....
4.
Blum H, Berg T, Tillmann H, von Weizsacker F
Z Gastroenterol
. 2004 Aug;
42(8):692-7.
PMID: 15314717
No abstract available.
5.
Spangenberg H, Thimme R, von Weizsacker F, Blum H
Internist (Berl)
. 2004 May;
45(7):777-85.
PMID: 15160245
Hepatocellular carcinoma (HCC) is one of the most common malignant tumors in some areas of the world. The major etiologic risk factors include toxins (alcohol, aflatoxin B(1)), hepatitis B and...
6.
Panther E, Spangenberg H, Neumann-Haefelin C, Rosler K, Blum H, von Weizsacker F, et al.
Z Gastroenterol
. 2004 Mar;
42(1):39-46.
PMID: 14997402
Infections with hepatitis B (HBV) and hepatitis C virus (HCV) are worldwide one of the most frequent causes for chronic liver disease, liver cirrhosis and hepatocellular carcinoma. The mechanisms responsible...
7.
Spangenberg H, Zuber-Jerger I, Thimme R, Blum H, von Weizsacker F
Zentralbl Chir
. 2003 Dec;
128(11):906-10.
PMID: 14669110
Hepatocellular carcinoma (HCC) is one of the most frequent malignancies worldwide. A variety of pharmacological strategies has been evaluated in the treatment of HCC: classical chemotherapy, tamoxifen, octreotide, thymostimulin, pravastatin,...
8.
Thimme R, Spangenberg H, von Weizsacker F, Blum H
Dtsch Med Wochenschr
. 2002 Oct;
127(43):2277-9.
PMID: 12397543
No abstract available.
9.
von Weizsacker F, Allgaier H, Blum H
Praxis (Bern 1994)
. 2002 Sep;
91(35):1393-5.
PMID: 12233281
Prevention is an increasingly important area of modern medicine. One of the foremost goals in the field of hepatology is prevention of hepatocellular carcinoma since this tumor has a poor...
10.
Kundgen L, Thoma C, Kock J, Wilting J, Koch K, Offensperger W, et al.
J Mol Med (Berl)
. 2002 Mar;
80(3):187-95.
PMID: 11894145
Resistance genes coding for inhibitors of hepadnaviral replication, such as ribozymes, antisense RNA, and dominant negative mutants have been shown to be effective in transfected hepatoma cells. In vivo studies,...